Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
Whether you’re advancing your knowledge or preparing for certification, you’ll find practical, evidence-based education to help you succeed.
Enter codeΒ Summer20 during checkout to save!
Sale ends July 13th, 2026
You are going to love the CDCES Boot Camp Online Prep Bundle aimed specifically for healthcare professionals preparing to pass the Certified Diabetes Care and Education Specialist (CDCES) exam and level-up their knowledge.
Original Pricing: Starting at $449
New Pricing: $399
Sale Price: $319.20
Kick-start your dream of achieving advanced certification starting today. Our evidence-based BC-ADM Boot Camp is designed for healthcare professionals preparing for the Board Certificate in Advanced Diabetes Management exam.
Original Pricing: Starting at $459
New Pricing: $399
Sale Price: $319.20
Our Dual Cert Boot Camp is a comprehensive program built specifically for healthcare professionals preparing for both the Certified Diabetes Care and Education Specialist (CDCES) exam and the Board Certified in Advanced Diabetes Management (BC-ADM) exam.
Original Pricing: Starting at $519
New Pricing: $499
Sale Price: $399.20
Our Certification Renewal Bundle gives you unlimited access to our entire Online University. With over 90 CE credits, this bundle is perfect for earning the CE credits you need while staying current with the latest evidence-based practices and ADA standards.
Original Pricing: Starting at $669
New Pricing: $599
Sale Price: $479.20
A 58-year-old man without a history of diabetes is receiving treatment with an immune checkpoint inhibitor for metastatic melanoma. Four months after beginning therapy, he presents with polyuria, weight loss, nausea, and fatigue.
Laboratory findings include:
Which mechanism most likely explains this sudden hyperglycemia?
πUpdated Schedule: ADA Boot Camp, Tech, MNT & More
Live in Beautiful San Diego – Oct 22-23, 2026
Re-Ignite your Passion & Prepare for Diabetes Certification Exams
π Earn 30+ CEs: AMA PRA Category 1 Creditsβ’, ACPE, ANCC, and CDR!
π
2-Day Conference
Oct 22β23, 2026
β±οΈ
15.5 Live CEs
+ 17 bonus CEs
π
CDCES & BC-ADM
Exam Prep + Renewal
π
San Diego, CA
1.7 mi from airport
The field of diabetes care is expanding and evolving rapidly. This unique training conference will keep you on the cutting edge plus prepare you for certification exams. It also fulfills the Standards of Care renewal requirement. Join us for two days of intensive education that is fun and inspiring. Add on the optional Day 3 (Engaging the Disengaged), to complete your conference exeperience.
Coach Beverly and Diana Isaacs, PharmD, BC-ADM, CDCES co-lead an exciting day that brings the ADA and AACE Standards to life. Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. After attending, you will be empowered to share the latest in diabetes care with your colleagues and the people in your care.
Take your knowledge to the next level with this intensive deep-dive into insulin therapy, dosing and pattern management with Dr. Diana Isaacs. Next, stay for the diabetes tech show-and-tell as Diana demonstrates the specs of the latest pumps and sensors. After lunch, nutrition whiz Christine Craig, MS, RDN, CDCES expertly details the latest in MNT and provides real strategies on translating this content to your clinical practice. You will have a chance to put it all together as Coach Beverly leads you through a series of case studies that integrates content from Day 1 and Day 2.
On Saturday, join this exceptional day-long program led by William H. Polonsky, PhD, CDCES & Susan Guzman, PhD (Behavioral Diabetes Institute) that reveals psychosocial forces behind diabetes self-management β tools to break through resistance and inspire change.
Read more below
π Essentials
Registration
+ Printed Syllabus
$559.00
π Deluxe
Essentials
+ ADA Standards Book
$589.00
π Complete – Best Value!
Deluxe
+ ADCES Review Guide e-Book
$669.00
Transform how you engage patients with diabetes β master behavior change, reduce distress, and overcome medication hesitancy.
Why do so many patients know what they should do β but still struggle to do it?
The answer lies in the psychology of diabetes.
In this transformative full-day course, world-renowned experts William H. Polonsky, PhD, CDCES, and Susan Guzman, PhD, from the Behavioral Diabetes Institute reveal the hidden psychosocial forces that drive β or derail β diabetes self-management.
Youβll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!
For last week’s practice question, we quizzed participants on self-efficacy and DSMES. 56% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it by clicking here.
A person with diabetes comes to your clinic and states she lost her spouse 18 months ago. She continues to have prolonged grief, shame, and guilt. She expresses how this is negatively impacting her having diabetes.
What is the best way to respond to increase her self-efficacy within DSMES?
Answer A is incorrect. 19.35% chose this answer, “Use motivation interviewing to help increase her self-management behaviors.” This answer is incorrect. Motivational interviewing is used as one component within a broader, structured psychotherapy called prolonged-grief therapy.
Answer B is incorrect. 8.06% of you chose this answer, “Help facilitate a support group to assist in problem solving.” This answer is incorrect. Individual psychotherapy has the strongest evidence verses for prolonged grief disorder.
Answer is incorrect. About 16.94% of respondents chose this: “Assist her with goal setting to address areas of her life she wants to improve.” This answer is incorrect. Goal setting alone is not the preferred treatment for someone with persistent grief 18 months after spousal loss. CBT or prolonged grief therapy 1st line of treatment.
Finally, Answer D is correct. 55.65% chose this answer, “Refer her to a counselor to help and address other areas of DSMES.” This answer is correct. The preferred first line treatment for a patient with persistent, impairing grief 18 months after spousal loss is grief-focused psychotherapy, specifically prolonged-grief therapy.
We hope you appreciate this weekβs rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Diabetes self-management education and support (DSMES) is essential for helping people with diabetes build knowledge and become empowered to manage their condition. Delivering the right content matters, and so does HOW that education is delivered. This course explores the behavioral strategies that support person-centered DSMES, helping you connect more effectively with the people you serve.
Course Objectives:
Upon completion of this activity, participants will be able to:
SW is a 52-year-old living with type 2 diabetes. Over the past year, A1C increased from 7.1% to 8.2%, and blood pressure during their visit was 146/88 mmHg. They report increased fatigue, daytime sleepiness, difficulty concentrating, and waking up several times during the night. SW works rotating night shifts at a manufacturing plant.
Which of the following responses would best align with the 2026 ADA Standards of Care?
Solve common glucose mysteries and optimize time-in-range for people with type 2 diabetes.
Why are glucose levels elevated in the morning? When should insulin be started? What is the next step to get A1c to target? During this course Coach Beverly addresses each of these glucose mysteries and more, using a person-centered approach. She describes a stepwise approach to evaluate glucose patterns and correct common issues encountered by people living with type 2 diabetes.
Course Topics:
Course Objectives
Upon completion of this activity, participants will be able to:
A person with diabetes comes to your clinic and states she lost her spouse 18 months ago. She continues to have prolonged grief, shame, and guilt. She expresses how this is negatively impacting her having diabetes.
What is the best way to respond to increase her self-efficacy within DSMES?
πUpdated Schedule: ADA Boot Camp, Tech, MNT & More
Live in Beautiful San Diego – Oct 22-23, 2026
Re-Ignite your Passion & Prepare for Diabetes Certification Exams
π Earn 30+ CEs: AMA PRA Category 1 Creditsβ’, ACPE, ANCC, and CDR!
π
2-Day Conference
Oct 22β23, 2026
β±οΈ
15.5 Live CEs
+ 17 bonus CEs
π
CDCES & BC-ADM
Exam Prep + Renewal
π
San Diego, CA
1.7 mi from airport
The field of diabetes care is expanding and evolving rapidly. This unique training conference will keep you on the cutting edge plus prepare you for certification exams. It also fulfills the Standards of Care renewal requirement. Join us for two days of intensive education that is fun and inspiring. Add on the optional Day 3 (Engaging the Disengaged), to complete your conference exeperience.
Coach Beverly and Diana Isaacs, PharmD, BC-ADM, CDCES co-lead an exciting day that brings the ADA and AACE Standards to life. Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. After attending, you will be empowered to share the latest in diabetes care with your colleagues and the people in your care.
Take your knowledge to the next level with this intensive deep-dive into insulin therapy, dosing and pattern management with Dr. Diana Isaacs. Next, stay for the diabetes tech show-and-tell as Diana demonstrates the specs of the latest pumps and sensors. After lunch, nutrition whiz Christine Craig, MS, RDN, CDCES expertly details the latest in MNT and provides real strategies on translating this content to your clinical practice. You will have a chance to put it all together as Coach Beverly leads you through a series of case studies that integrates content from Day 1 and Day 2.
On Saturday, join this exceptional day-long program led by William H. Polonsky, PhD, CDCES & Susan Guzman, PhD (Behavioral Diabetes Institute) that reveals psychosocial forces behind diabetes self-management β tools to break through resistance and inspire change.
Read more below
π Essentials
Registration
+ Printed Syllabus
$559.00
π Deluxe
Essentials
+ ADA Standards Book
$589.00
π Complete – Best Value!
Deluxe
+ ADCES Review Guide e-Book
$669.00
Transform how you engage patients with diabetes β master behavior change, reduce distress, and overcome medication hesitancy.
Why do so many patients know what they should do β but still struggle to do it?
The answer lies in the psychology of diabetes.
In this transformative full-day course, world-renowned experts William H. Polonsky, PhD, CDCES, and Susan Guzman, PhD, from the Behavioral Diabetes Institute reveal the hidden psychosocial forces that drive β or derail β diabetes self-management.
Youβll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!
Author: Beverly Thomassian, RN, MPH, CDCES, BC-ADM
CEO & President, DiabetesEd Services
For decades, healthcare professionals have cared for individuals diagnosed with Polycystic Ovary Syndrome (PCOS), a condition that affects approximately 1 in 8 women worldwide. Yet many clinicians, researchers, and people living with the condition have long felt that the name never fully captured the complexity of what was happening beneath the surface.
In May 2026, a landmark international consensus published in the Lancet, officially renamed PCOS to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change emerged from more than a decade of collaboration among global experts, patient advocates, and professional organizations seeking a name that better reflects the conditionβs true nature and broad health implications.
The term “polycystic ovary syndrome” has created confusion for years. Many people diagnosed with PCOS do not actually have ovarian cysts, while others with ovarian cysts do not have the syndrome. The previous name often led healthcare providers to focus primarily on reproductive concerns while overlooking significant metabolic and endocrine dysfunction.
The new nameβPolyendocrine Metabolic Ovarian Syndromeβhighlights what many clinicians have recognized for years: this is a complex, whole-body condition involving hormonal regulation, metabolism, reproductive health, cardiovascular risk, and mental well-being.
As healthcare professionals, we know that language shapes understanding. A diagnosis is often the first framework through which a person interprets their health condition.
When the name focuses narrowly on ovaries and cysts, important aspects of care can be missed. The new terminology helps communicate that PMOS is not simply a reproductive disorderβit is a lifelong endocrine and metabolic condition requiring multidisciplinary care. Experts hope the renaming will reduce stigma, improve diagnostic accuracy, and stimulate greater research investment in prevention and treatment strategies.
This shift is reminiscent of the transition from NAFLD to MASLD, where updated terminology was designed to better reflect underlying pathophysiology and reduce misunderstanding. In both cases, language serves as a tool to improve clinical care and patient outcomes.
As a healthcare professional providing care to people with diabetes, you are likely to encounter individuals with undiagnosed and undertreated PMOS. Since insulin resistance is an underlying disorder in both conditions, there is a bidirectional relationship between diabetes and PMOS.
You can be on the lookout for individuals with PMOS and advocate for diagnosis and evidence-based treatments. These individuals may be struggling to cope with the complex metabolic and social consequences associated with PMOS. Β
PMOS, is a complex condition that can present differently from person to person. While some individuals experience reproductive symptoms, others may first notice metabolic changes or signs of excess androgen activity.
Not everyone with PMOS has overweight or obesity. Up to 20β30% of individuals may have a normal BMI yet still experience insulin resistance, androgen excess, ovulatory dysfunction, or cardiometabolic risk. This is one reason why relying solely on weight can lead to delayed diagnosis.
When working with individuals who have PMOS, consider:
Many people living with PMOS have spent years feeling dismissed or misunderstood. A whole-person approach that validates their experiences can be just as important as the pharmacologic interventions we recommend.
The central focus is on improving metabolic health, managing symptoms, and supporting individual goals such as fertility or diabetes prevention.
Lifestyle interventions – including regular physical activity, nutritious foods, adequate sleep, and stress management, remain the foundation of care.
Medications–Β the following medications are used to improve glucose levels, decrease insulin resistance and support a healthy weight.
Combined hormonal contraceptives can help regulate menstrual cycles and reduce symptoms of androgen excess, while spironolactone may be prescribed for acne or excess hair growth.
Assessing for Co-Conditions – Given the increased risk of prediabetes, type 2 diabetes, hypertension, dyslipidemia, sleep apnea, and mental health concerns, comprehensive screening and a person-centered, multidisciplinary approach are essential components of long-term PMOS care.
Many people with PMOS spend years seeking answers before receiving a diagnosis. Symptoms such as weight changes, irregular periods, acne, or excess hair growth can carry significant emotional burdens. Approaching these conversations with curiosity, empathy, and non-stigmatizing language can help foster trust and improve engagement in care.
PMOS is far more than a reproductive condition. It is a lifelong endocrine and metabolic disorder that may affect reproductive health, glucose metabolism, cardiovascular risk, sleep, and emotional well-being. Recognizing the early signs can lead to earlier intervention and better long-term outcomes.
The renaming to PMOS offers an opportunity for diabetes health care professionals to strengthen interdisciplinary collaboration and advocate for best care.
Beverly Thomassian, RN, MPH, CDCES, BC-ADM
CEO & President, DiabetesEd Services
Are you a healthcare professional providing diabetes care in an under-resourced community? Are you working toward earning your certification in diabetes education (CDCES or BC-ADM?)
If yes, please consider applying for our Bridge Scholarship, which covers the registration cost for the DiabetesEd Training Conference in San Diego, Oct 22-23, 2026 (value of $559). This program will provide you with the content needed to prepare for mastery-level diabetes certification and beyond!
Recipients will be awarded the Training Conference reg fee, including the live program, printed syllabus, 30+ CE’s, plus access to the online bonus courses for one year! Applications Due on July 20th, 2026
πUpdated Schedule: ADA Boot Camp, Tech, MNT & More
Live in Beautiful San Diego – Oct 22-23, 2026
Re-Ignite your Passion & Prepare for Diabetes Certification Exams
π Earn 30+ CEs: AMA PRA Category 1 Creditsβ’, ACPE, ANCC, and CDR!
π
2-Day Conference
Oct 22β23, 2026
β±οΈ
15.5 Live CEs
+ 17 bonus CEs
π
CDCES & BC-ADM
Exam Prep + Renewal
π
San Diego, CA
1.7 mi from airport
The field of diabetes care is expanding and evolving rapidly. This unique training conference will keep you on the cutting edge plus prepare you for certification exams. It also fulfills the Standards of Care renewal requirement. Join us for two days of intensive education that is fun and inspiring. Add on the optional Day 3 (Engaging the Disengaged), to complete your conference exeperience.
Coach Beverly and Diana Isaacs, PharmD, BC-ADM, CDCES co-lead an exciting day that brings the ADA and AACE Standards to life. Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. After attending, you will be empowered to share the latest in diabetes care with your colleagues and the people in your care.
Take your knowledge to the next level with this intensive deep-dive into insulin therapy, dosing and pattern management with Dr. Diana Isaacs. Next, stay for the diabetes tech show-and-tell as Diana demonstrates the specs of the latest pumps and sensors. After lunch, nutrition whiz Christine Craig, MS, RDN, CDCES expertly details the latest in MNT and provides real strategies on translating this content to your clinical practice. You will have a chance to put it all together as Coach Beverly leads you through a series of case studies that integrates content from Day 1 and Day 2.
On Saturday, join this exceptional day-long program led by William H. Polonsky, PhD, CDCES & Susan Guzman, PhD (Behavioral Diabetes Institute) that reveals psychosocial forces behind diabetes self-management β tools to break through resistance and inspire change.
Read more below
π Essentials
Registration
+ Printed Syllabus
$559.00
π Deluxe
Essentials
+ ADA Standards Book
$589.00
π Complete – Best Value!
Deluxe
+ ADCES Review Guide e-Book
$669.00
Transform how you engage patients with diabetes β master behavior change, reduce distress, and overcome medication hesitancy.
Why do so many patients know what they should do β but still struggle to do it?
The answer lies in the psychology of diabetes.
In this transformative full-day course, world-renowned experts William H. Polonsky, PhD, CDCES, and Susan Guzman, PhD, from the Behavioral Diabetes Institute reveal the hidden psychosocial forces that drive β or derail β diabetes self-management.
Youβll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!
“I’ve managed my diabetes for years, but ever since starting cancer treatment, my blood glucose has been all over the place. I don’t know what I am doing wrong.”
As diabetes health professionals, our job is to support people through both complex clinical situations and the emotional challenges of living with cancer and diabetes. Having the knowledge to address both can improve engagement, lead to better outcomes, and strengthen relationships with the people we work with.
Diabetes and cancer are no longer just parallel health crises sharing a personβs chart; they are deeply entangled pathologies where hyperglycemia, inflammation and the risk of cancer development are interrelated. For diabetes healthcare professionals, mastering this bidirectional threat no longer falls under the rare case scenario.
Β As a diabetes professional, you have an important role in detecting sudden hyperglycemia as a result of chemotherapeutic agents, like checkpoint inhibitors and PI3k inhibitors. In addition, you can encourage people with diabetes to engage in regular cancer screenings and be aware of reportable symptoms. This is an immediate, high-stakes clinical mandate that can improve prompt treatment and detect cancer earlier.
The shared risk factors between type 2 diabetes and cancer (older age, elevated body weight, and lack of physical activity) increase this bidirectional association, but diabetes-related factors such as underlying disease physiology or diabetes treatments may also increase this cancer-diabetes connection.
One of the most clinically actionable areas of recent research highlights the relationship between a new diabetes diagnosis and pancreatic and other cancers.
People with type 2 diabetes face about twice the risk of developing pancreatic cancer compared to those without the condition, while an older adult (over 50) with new-onset diabetes experiences a sharper increase in risk within the first few years.
New onset of atypical diabetes (lean body habitus and negative family history) in a middle-aged or older person may precede the diagnosis of pancreatic adenocarcinoma. Additionally, in a nationwide cancer registry in New Zealand, post pancreatitis diabetes mellitus was associated with significantly higher risk (2.4-fold) of pancreatic cancer compared with pancreatitis after type 2 diabetes. (ADA).
Diabetes is associated with increased risk of cancers of the liver, pancreas, endometrium, colon and rectum, breast, and bladder.
Large-scale cohort analyses reveal that individuals with diabetes face a roughly doubled risk of developing
There are also notable 1.2- to 1.5-fold increases in:
People with diabetes are encouraged to schedule recommended age-and sex-appropriate cancer screenings, coordinated with their primary health care professional. As diabetes professionals, you can encourage individuals to take action and to reduce their modifiable cancer risk factors. Actions that help with diabetes management also reduce risk of cancer including:
The cancer frontier of oncology has been revolutionized by precision therapies, but these life-saving advancements can come with steep glucose elevations due to beta cell disruption.
Hyperglycemia due to chemotherapy may either be transient (improving upon treatment cessation) or represent permanent diabetes.
Immune checkpoint inhibitors are used to treat many types of cancer, such as melanoma, non-small cell lung cancer, bladder cancer, renal cell carcinoma, breast cancer, and Hodgkin lymphoma.
Common immune checkpoint inhibitors include: pembrolizumab (Keytruda), nivolumab (Opdivo), ipilimumab (Yervoy), durvalumab (Imfinzi), atezolizumab (Tecentriq).
The most likely Immune checkpoint inhibitors that rigger rapid, autoimmune-mediated destruction of beta cells include:
Insulin therapy is the cornerstone of management, as individuals typically present with rapid-onset, severe hyperglycemia or DKA. Many will initially need an insulin drip, followed by the implementation of basal bolus insulin therapy along with continuous glucose monitoring.
PI3K inhibitors are used primarily to treat advanced breast cancer (specifically HR+/HER2- tumors with PIK3CA mutations) and blood cancers (such as lymphomas, leukemias, and follicular lymphoma).
Phosphatidylinositol 3-kinase (PI3K) inhibitors are small molecules designed to disrupt intracellular signaling pathways, thereby inhibiting cancer cell growth and survival. Within this class, targeted inhibition of the alpha isoform (PI3KΞ±) disrupts downstream insulin receptor signaling, frequently resulting in profound, on-target hyperglycemia and acute insulin resistance.
Which PI3K medications are associated with glucose elevations?
These two types of PI3KΞ± inhibitors have a 60% incidence of causing hyperglycemia, typically appearing within the first 2 weeks of therapy.
People at increased risk of hyperglycemia from PI3K inhibitor therapy include those with:
Glucose management is crucial since significant hyperglycemia can lead to discontinuation and/or reduction in PI3K medication dose, which can decrease therapy efficacy.
Cancer treatment often includes concurrent steroid therapy to enhance efficacy. However, steroid therapy can induce or worsen hyperglycemia.
Steroids have their highest potency at 4-12 hours, with the exception of the very potent dexamethasone, which has a half life of 1-2 days.
With morning steroids, including dexamethasone, people will experience elevated glucose values after breakfast, lunch, dinner, and at bedtime but will have a significant drop toward normal glucose overnight.
Therefore, hyperglycemia is greatest 1β2 hours after a meal, with persistent elevation until the following meal, followed by a return to normal overnight.
To treat steroid induced hyperglycemia, NPH. Neutral Protamine Hagedorn (NPH) insulin is an effective treatment choice since it is an intermediate acting basal insulin. NPH insulin is cloudy and has an onset of 1β4 hours. Its peak is 6β10 hours and its duration is about 10β16 hours. Download our Insulin PocketCards.Β
For individuals on once daily steroids, morning NPH with some bolus insulin can effectively target daytime hyperglycemia. For those taking steroids twice daily, an additional dose of NPH plus bolus as needed, is added atΒ dinnertime.
Join Coach Beverly July 21 at 11:30am to learn more during our Cancer and Diabetes Webinar.
As diabetes professionals, we are stepping into a vital new role at the intersection of metabolic health and oncology. Modern cancer therapies like checkpoint inhibitors and PI3K inhibitors are absolute game-changers for oncology, but they often trigger sudden, severe hyperglycemia that catches patients and healthcare professionals off guard.
That is where our expertise becomes a literal lifesaver. By actively monitoring for sudden hyperglycemia and aggressively championing routine cancer screenings, we are doing so much more than just managing a chronic disease. We are taking on an urgent, high-stakes clinical mandate that ensures patients get immediate treatment when they need it most and catches cancer at its earliest, most treatable stages.
Ultimately, our vigilance bridges the gap between effective cancer therapy and safe metabolic health, directly shaping better, life-saving outcomes for the people in our care.
Explore the unexpected link between cancer and diabetes β and master glucose management strategies for people with diabetes undergoing treatment.
Individuals with cancer often experience hyperglycemia secondary to treatment, which can increase the risk of infection and other complications. Recent research has also identified a significant link between diabetes and cancer. This course uses a case study approach to explore this connection and provide practical strategies for managing steroid-induced hyperglycemia and improving quality of life for people navigating both conditions.
Course Topics:
Celebrations are in order!
June is Pride Month – a time to honor diversity, inclusion, and the freedom to be authentically ourselves. It’s also a special month for another reason – today is my birthday! π
This month, we have lots of exciting updates to share with you!
First, the term PCOS has been updated to PMOS (Polyendocrine Metabolic Ovarian Syndrome), recognizing that this common condition is far more complex than the presence of ovarian cysts. Coach Beverly explores the significance of this name change along with key risk factors and treatment considerations.
Β Continued below…
How many times has a worried patient asked you, “Is it okay to eat fruit?” Our nutrition expert, Christine Craig, provides a timely refresher on the glycemic impact of summer fruits and shares practical strategies for people with diabetes to enjoy them while supporting glucose management.
Did you know that the CBDCE is exploring a new certification pathway for healthcare support staffβthe team members who are often the first point of contact for people seeking diabetes care? Diabetes expert Sarah Hormachea takes a closer look at this exciting development in her article, “Beyond the CDCES.”
Diabetes pharmacotherapy continues to evolve at lightning speed. Fortunately, we’re keeping track of the latest medication approvals, indication changes, and updates so you don’t have to. Be sure to check out the newest additions and revisions to our Medication PocketCards highlighted below.
Test your knowledge with our Question and Rationale of the Week too!
As I write this, I’m on a plane headed to the ADA Scientific Sessions in New Orleans. I can’t wait to learn, connect, and bring back the latest clinical pearls and practice-changing updates to share with you. If you’ll be attending, please stop and say helloβI would love to meet you!
Thank you for being part of a community that embraces compassion, curiosity, and connection.
With hearts full of gratitude,
Coach Beverly, Bryanna, Ashlie, and Katarina
Are you a healthcare professional providing diabetes care in an under-resourced community? Are you working toward earning your certification in diabetes education (CDCES or BC-ADM?)
If yes, please consider applying for our Bridge Scholarship, which covers the registration cost for the DiabetesEd Training Conference in San Diego, Oct 22-23, 2026 (value of $559). This program will provide you with the content needed to prepare for mastery-level diabetes certification and beyond!
Recipients will be awarded the Training Conference reg fee, including the live program, printed syllabus, 30+ CE’s, plus access to the online bonus courses for one year! Applications Due on July 20th, 2026
πUpdated Schedule: ADA Boot Camp, Tech, MNT & More
Live in Beautiful San Diego – Oct 22-23, 2026
Re-Ignite your Passion & Prepare for Diabetes Certification Exams
π Earn 30+ CEs: AMA PRA Category 1 Creditsβ’, ACPE, ANCC, and CDR!
π
2-Day Conference
Oct 22β23, 2026
β±οΈ
15.5 Live CEs
+ 17 bonus CEs
π
CDCES & BC-ADM
Exam Prep + Renewal
π
San Diego, CA
1.7 mi from airport
The field of diabetes care is expanding and evolving rapidly. This unique training conference will keep you on the cutting edge plus prepare you for certification exams. It also fulfills the Standards of Care renewal requirement. Join us for two days of intensive education that is fun and inspiring. Add on the optional Day 3 (Engaging the Disengaged), to complete your conference exeperience.
Coach Beverly and Diana Isaacs, PharmD, BC-ADM, CDCES co-lead an exciting day that brings the ADA and AACE Standards to life. Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. After attending, you will be empowered to share the latest in diabetes care with your colleagues and the people in your care.
Take your knowledge to the next level with this intensive deep-dive into insulin therapy, dosing and pattern management with Dr. Diana Isaacs. Next, stay for the diabetes tech show-and-tell as Diana demonstrates the specs of the latest pumps and sensors. After lunch, nutrition whiz Christine Craig, MS, RDN, CDCES expertly details the latest in MNT and provides real strategies on translating this content to your clinical practice. You will have a chance to put it all together as Coach Beverly leads you through a series of case studies that integrates content from Day 1 and Day 2.
On Saturday, join this exceptional day-long program led by William H. Polonsky, PhD, CDCES & Susan Guzman, PhD (Behavioral Diabetes Institute) that reveals psychosocial forces behind diabetes self-management β tools to break through resistance and inspire change.
Read more below
π Essentials
Registration
+ Printed Syllabus
$559.00
π Deluxe
Essentials
+ ADA Standards Book
$589.00
π Complete – Best Value!
Deluxe
+ ADCES Review Guide e-Book
$669.00
Transform how you engage patients with diabetes β master behavior change, reduce distress, and overcome medication hesitancy.
Why do so many patients know what they should do β but still struggle to do it?
The answer lies in the psychology of diabetes.
In this transformative full-day course, world-renowned experts William H. Polonsky, PhD, CDCES, and Susan Guzman, PhD, from the Behavioral Diabetes Institute reveal the hidden psychosocial forces that drive β or derail β diabetes self-management.
Youβll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!